The groundbreaking rise of Viagra has consistently remained a symbol of pharmaceutical success, yet its future within the broader industry now triggers questions about long-term yields . Generic versions are eroding market share, causing worries that betting on companies closely tied to Viagra's previous influence could be a dangerous decision , es